Literature DB >> 15611070

Binding of Rad51 and other peptide sequences to a promiscuous, highly electrostatic binding site in p53.

Assaf Friedler1, Dmitry B Veprintsev, Trevor Rutherford, Karoly I von Glos, Alan R Fersht.   

Abstract

Homologous recombination is repressed by the binding of p53 to Rad51. We identified by fluorescence and NMR spectroscopy that peptides corresponding to residues 179-190 of Rad51 bind to the core domain of p53 in a site that overlaps with its specific DNA binding site. The p53 site is quite promiscuous, since it also binds peptides derived from 53BP1, 53BP2, Hif-1alpha, and BCL-X(L) in overlapping regions. Binding is mediated mainly by a strong, nonspecific, electrostatic component and is fine tuned by specific interactions. Competition of the different proteins with each other and with specific DNA for a single site in p53 could be a factor in regulation of its activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611070     DOI: 10.1074/jbc.M411176200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Functional census of mutation sequence spaces: the example of p53 cancer rescue mutants.

Authors:  Samuel A Danziger; S Joshua Swamidass; Jue Zeng; Lawrence R Dearth; Qiang Lu; Jonathan H Chen; Jianlin Cheng; Vinh P Hoang; Hiroto Saigo; Ray Luo; Pierre Baldi; Rainer K Brachmann; Richard H Lathrop
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2006 Apr-Jun       Impact factor: 3.710

2.  Specificity in molecular design: a physical framework for probing the determinants of binding specificity and promiscuity in a biological environment.

Authors:  Mala L Radhakrishnan; Bruce Tidor
Journal:  J Phys Chem B       Date:  2007-11-03       Impact factor: 2.991

3.  Choosing where to look next in a mutation sequence space: Active Learning of informative p53 cancer rescue mutants.

Authors:  Samuel A Danziger; Jue Zeng; Ying Wang; Rainer K Brachmann; Richard H Lathrop
Journal:  Bioinformatics       Date:  2007-07-01       Impact factor: 6.937

4.  Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium.

Authors:  Zvi Hayouka; Joseph Rosenbluh; Aviad Levin; Shoshana Loya; Mario Lebendiker; Dmitry Veprintsev; Moshe Kotler; Amnon Hizi; Abraham Loyter; Assaf Friedler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

5.  Identification of transient hub proteins and the possible structural basis for their multiple interactions.

Authors:  Miho Higurashi; Takashi Ishida; Kengo Kinoshita
Journal:  Protein Sci       Date:  2008-01       Impact factor: 6.725

6.  Overexpression of RAD51 occurs in aggressive prostatic cancer.

Authors:  Anita Mitra; Charles Jameson; Yolanda Barbachano; Lydia Sanchez; Zsofia Kote-Jarai; Susan Peock; Nayanta Sodha; Elizabeth Bancroft; Anne Fletcher; Colin Cooper; Douglas Easton; Rosalind Eeles; Christopher S Foster
Journal:  Histopathology       Date:  2009-12       Impact factor: 5.087

7.  Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents.

Authors:  Guangan He; Xiaolei Xie; Zahid H Siddik
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-28       Impact factor: 3.333

8.  Human cancer protein-protein interaction network: a structural perspective.

Authors:  Gozde Kar; Attila Gursoy; Ozlem Keskin
Journal:  PLoS Comput Biol       Date:  2009-12-11       Impact factor: 4.475

9.  Structural and functional implications of p53 missense cancer mutations.

Authors:  Yuhong Tan; Ray Luo
Journal:  PMC Biophys       Date:  2009-06-26

10.  Predicting positive p53 cancer rescue regions using Most Informative Positive (MIP) active learning.

Authors:  Samuel A Danziger; Roberta Baronio; Lydia Ho; Linda Hall; Kirsty Salmon; G Wesley Hatfield; Peter Kaiser; Richard H Lathrop
Journal:  PLoS Comput Biol       Date:  2008-09-04       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.